50 Deep Tech Startups in Cambridge to Watch in 2024

Human microbiome therapeutics developer creating live bacterial treatments and biomarkers.

Transforming mental healthcare by unlocking the power of clinical data

Platform for understanding and defining the biological codes that make up human cells.

"Biotechnology platform producing sugar substitutes."

Desktop technology making biology accessible by synthesizing proteins and genes.

Contract Research Organization specializing in bioscience research services.

Platform enabling the development of cell therapies through advanced reprogramming techniques.

Fibroblast technology designed to develop new therapies for diseases.

Cancer immunotherapeutics company working across the Atlantic.

Pet therapeutics startup dedicated to developing medicines for pets.

Manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications.

Cancer diagnostics.

Supplier of configurable process node agnostic analog IP building blocks.

Independent biotech company focused on developing new cancer therapies targeting DNA damage response.

Platform using epigenetics to simplify routine diagnostic tests for common cancers to a simple blood draw.

Platform specializing in single cell analysis and characterization, offering related R&D services.

Novel cancer therapies.

Drug discovery company based in Cambridge, UK.

Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.

CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.

Treatment for patients with chronic wounds.

Platform for increasing protein production in the body using specialized translation enhancers.

Biopharmaceutical company focused on drug discovery and development for protein misfolding diseases.

Platform technology overcoming antibacterial resistance.

Platform identifying chemical starting points to speed up drug discovery at lower costs.

Platform for life science professionals to connect with global experts for strategic engagement.

Biotechnology company focused on targeting deubiquitinase enzymes for cancer therapy.

Drug discovery company focusing on developing bone morphogenetic proteins since 2015.

Molecular therapies for cancer patients.

Supplier of protein research tools for scientific studies.

A multi-disciplinary team, based in Cambridge, working to solve some of the most difficult problems in biotechnology.

Platform for creating next-generation biotherapeutics.

Platform offering precision oncology solutions to improve cancer treatment.

Platform for developing proprietary drugs using VH antibody fragments.

Technology that advances genomics through innovative NGS techniques.

Human cell provider for drug discovery use in lead optimization and toxicity programs.

Technology for accelerating vaccine development and achieving significant improvements.

Produce pure, mature and highly consistent batches of human cell types for research, toxicology and drug development.

Biotech firm specializing in alternative splicing of VEGF for eye disease treatments.

F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.

Software platform designed for urban mobility solutions in public transport within complex city environments.

Tools that revolutionize how proteins are characterized.

Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health.

Lightcast uses a microfluidic platform to make advances towards unique clinical approaches, new therapies, and innovative products.

An innovator in life science reagents and tools serving life science researchers globally to achieve their mission, faster.

Biopharmaceutical developer creating innovative treatments for microbial infections.

Platform for reducing costs and improving the efficiency of genomics data processing.

Platform developing innovative drugs for cancer treatment.

Therapies designed to achieve long-term disease remission with less frequent doses.

Platform that enhances images by using patented Image Fusion technology and Deep Learning to reveal more color, detail, and clarity.